Asia Pacific Allergy Immunotherapies Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and Geography

No. of Pages: 115    |    Report Code: TIPRE00014186    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Allergy Immunotherapies Market

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1      Asia Pacific Allergy Immunotherapies Market – By Treatment

1.3.2      Asia Pacific Allergy Immunotherapies Market – By Allergy Type

1.3.3      Asia Pacific Allergy Immunotherapies Market – By Distribution Channel

1.3.4      Asia Pacific Allergy Immunotherapies Market – By Geography

2.          Asia Pacific Allergy Immunotherapies Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Allergy Immunotherapies Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1      Asia-Pacific – PEST Analysis

4.3        Expert Opinion

5.          Asia Pacific Allergy immunotherapies Market – Key Market Dynamics

5.1        Key Market Drivers

5.1.1      Growing Prevalence of Allergic Disorders

5.1.2      Technological Advancements in Sublingual Dosage Formulations

5.2        Key Market Restraint

5.2.1      Drawbacks Associated with the Use of Allergy Immunotherapy

5.2.2      Regulatory Variations Across Regions

5.3        Key Market Opportunities

5.3.1      Expansion of Pharmacy across Globe

5.4        Future Trends

5.4.1      Increasing Research and Development for Drugs

5.5        Impact Analysis

6.          Allergy Immunotherapies Market – Asia Pacific Analysis

6.1.1      Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)

7.          Asia Pacific Allergy Immunotherapies Market Analysis– by Treatment

7.1        Overview

7.2        Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)

7.3        Subcutaneous Immunotherapy (SCIT)

7.3.1      Overview

7.4        Sublingual Immunotherapy (SLIT)

7.4.1      Overview

7.4.2      Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

8.          Allergy Immunotherapies Market Analysis– by Allergy Type

8.1        Overview

8.2        Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)

8.3        Allergic Rhinitis

8.3.1      Overview

8.3.2      Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

8.4        Asthma

8.4.1      Overview

8.4.2      Asthma Market Revenue and Forecasts to 2027 (US$ Million)

8.5        Food Allergy

8.5.1      Overview

8.5.2      Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.6        Venom Allergy

8.6.1      Overview

8.6.2      Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.7        Other Allergies

8.7.1      Overview

8.7.2      Others Market Revenue and Forecasts to 2027 (US$ Million)

9.          Allergy Immunotherapies Market Analysis– by Distribution Channel

9.1        Overview

9.2        Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)

9.3        Hospital Pharmacy

9.3.1      Overview

9.3.2      Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

9.4        Retail Pharmacy

9.4.1      Overview

9.4.2      Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

9.5        Online Pharmacy

9.5.1      Overview

9.5.2      Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

10.       Allergy Immunotherapies Market Analysis And Forecasts To 2027 – Geographical Analysis

10.1 Asia-Pacific: Allergy Immunotherapies Market

10.1.1   Overview

10.1.2   Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)

10.1.3   Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.4   Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.5   Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6   Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)

10.1.7   China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.8   Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.9   India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.10 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.10.3    South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.4    South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.11 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.11.3    Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.11.4    Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.       Impact of COVID-19 Pandemic on Asia Pacific Allergy Immunotherapies Market

11.1     Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.       Company Profiles

12.1     ALK-Abelló A/S

12.1.1   Key Facts

12.1.2   Business Description

12.1.3   Products and Services

12.1.4   Financial Overview

12.1.5   SWOT Analysis

12.1.6   Key Developments

12.2     Stallergenes Greer

12.2.1   Key Facts

12.2.2   Business Description

12.2.3   Products and Services

12.2.4   Financial Overview

12.2.5   SWOT Analysis

12.2.6   Key Developments

12.3     HAL Allergy B.V.

12.3.1   Key Facts

12.3.2   Business Description

12.3.3   Products and Services

12.3.4   Financial Overview

12.3.5   SWOT Analysis

12.3.6   Key Developments

12.4     Johnson and Johnson Services, Inc.

12.4.1   Key Facts

12.4.2   Business Description

12.4.3   Products and Services

12.4.4   Financial Overview

12.4.5   SWOT Analysis

12.4.6   Key Developments

12.5     Anergis

12.5.1   Key Facts

12.5.2   Business Description

12.5.3   Products and Services

12.5.4   Financial Overview

12.5.5   SWOT Analysis

12.5.6   Key Developments

12.6     DBV Technologies

12.6.1   Key Facts

12.6.2   Business Description

12.6.3   Products and Services

12.6.4   Financial Overview

12.6.5   SWOT Analysis

12.6.6   Key Developments

12.7     Allergy Therapeutics

12.7.1   Key Facts

12.7.2   Business Description

12.7.3   Products and Services

12.7.4   Financial Overview

12.7.5   SWOT Analysis

12.7.6   Key Developments

13.       Appendix

13.1     Glossary of Terms

LIST OF TABLES

Table 1.            Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 2.            Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 3.            Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 4.            China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 5.            China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.            Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 8.            Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 9.            Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 10.         India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 11.         India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 12.         India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.         South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14.         South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 15.         South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 16.         Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 17.         Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 18.         Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 19.         Glossary of Terms, Allergy Immunotherapies Market

LIST OF FIGURES

Figure 1.          Allergy Immunotherapies Market Segmentation

Figure 2.          Asia Pacific Allergy Immunotherapies Market Overview

Figure 3.          Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market

Figure 4.          Asia-Pacific to Show Remarkable Growth During Forecast Period

Figure 6.          Global Allergy Immunotherapies Market- Leading Country Markets (US$ Million)

Figure 7.          Asia-Pacific PEST Analysis

Figure 8.          Allergy immunotherapies Market Impact Analysis of Driver and Restraints

Figure 9.          Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)

Figure 10.        Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)

Figure 11.        Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 12.        Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 13.        Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)

Figure 14.        Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

Figure 15.        Asthma Market Revenue and Forecasts to 2027 (US$ Million)

Figure 16.        Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 17.        Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 18.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 19.        Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)

Figure 20.        Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 21.        Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

Figure 22.        Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 23.        Asia-Pacific: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)

Figure 24.        Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)

Figure 25.        Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)

Figure 26.        China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Impact of COVID-19 Pandemic on allergy immunotherapies market in Asia Pacific Countries

 

The List of Companies - Asia Pacific Allergy Immunotherapies Market

  1. HAL Allergy B.V.
  2. ALK Abello A/S
  3. Stallergenes Greer
  4. Anergis
  5. Circassia